Johnson & Johnson

NYSE-JNJ

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Jan '16	Jan '17	Dec '17	Dec '18	Dec '19	Jan '21	Jan '22	Jan '23	Dec '23	LTM
Total Revenues						82,059	82,584	78,740	79,990	85,159	86,576
Total Revenues % Chg.						0.6%	0.6%	-4.7%	1.6%	6.5%	5.1%
Cost of Goods Sold, Total						27,556	28,427	23,402	24,596	26,244	26,466
Gross Profit						54,503	54,157	55,338	55,394	58,915	60,110
Selling General & Admin Expenses, Total						21,885	21,731	19,506	19,078	20,166	21,050
R&D Expenses						11,355	12,159	14,277	14,135	15,085	14,909
Other Operating Expenses, Total						33,240	33,890	33,783	33,213	35,251	35,959
Operating Income						21,263	20,267	21,555	22,181	23,664	24,151
Interest Expense, Total						-318	-201	-183	-276	-772	-768
Interest And Investment Income						357	111	53	490	1,261	1,496
Net Interest Expenses						39	-90	-130	214	489	728
Currency Exchange Gains (Loss)						-267	-209	-216	-286	-366	-326
Other Non Operating Income (Expenses)						-3,909	-2,922	-550	1,744	1,664	1,929
EBT, Excl. Unusual Items						17,126	17,046	20,659	23,853	25,451	26,482
Restructuring Charges	—					-266	-247	-209	-275	-798	-683
Merger & Related Restructuring Charges			—	—	—	—	—	—	-300	-200	-600
Gain (Loss) On Sale Of Investments	—	—	—	—	—	300	1	—	-700	-600	-920
Gain (Loss) On Sale Of Assets						2,154	111	617	380	117	270
Asset Writedown	—					-1,096	-233	-989	-1,216	-1,295	-1,286
In Process R&D Expenses						-890	-181	-900	-783	-313	-458
Legal Settlements			—	—	—	—	—	—	-900	-6,900	-3,200
Other Unusual Items	—	—	—	—	—	—	—	—	-700	-400	-100
EBT, Incl. Unusual Items						17,328	16,497	19,178	19,359	15,062	19,505
Income Tax Expense						2,209	1,783	1,377	2,989	1,736	3,123
Earnings From Continuing Operations						15,119	14,714	17,801	16,370	13,326	16,382
Earnings Of Discontinued Operations	—	—	—	—	—	—	—	3,077	1,571	21,827	21,636
Net Income						15,119	14,714	20,878	17,941	35,153	38,018
Net Income to Common Incl Extra Items						15,119	14,714	20,878	17,941	35,153	38,018
Net Income to Common Excl. Extra Items						15,119	14,714	17,801	16,370	13,326	16,382
Total Shares Outstanding						2,632.5	2,632.5	2,629	2,613.6	2,407.1	2,406.8
Weighted Avg. Shares Outstanding						2,645.1	2,632.8	2,632.1	2,625.2	2,533.5	2,436.3
Weighted Avg. Shares Outstanding Dil						2,684.3	2,670.7	2,674	2,663.9	2,560.4	2,459.3
EPS						5.7	5.6	7.9	6.8	13.9	15.6
EPS Diluted						5.6	5.5	7.8	6.7	13.7	15.5
EBITDA						28,272	27,498	28,206	28,510	30,767	31,037
Effective Tax Rate						12.7%	10.8%	7.2%	15.4%	11.5%	16%